SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $579,553 | +1.1% | 4,781 | -4.5% | 0.27% | +2.3% |
| Q2 2023 | $573,173 | -46.1% | 5,005 | -35.1% | 0.26% | -69.7% |
| Q1 2023 | $1,063,083 | +6.4% | 7,713 | 0.0% | 0.87% | +46.0% |
| Q4 2022 | $999,451 | +12.9% | 7,713 | -3.7% | 0.59% | +17.4% |
| Q3 2022 | $885,000 | +23.3% | 8,009 | -16.4% | 0.50% | +16.6% |
| Q2 2022 | $718,000 | -18.8% | 9,581 | -15.3% | 0.43% | -23.0% |
| Q1 2022 | $884,000 | -8.5% | 11,310 | +99.6% | 0.56% | -8.9% |
| Q4 2020 | $966,000 | +134.5% | 5,667 | +120.5% | 0.62% | +80.9% |
| Q2 2020 | $412,000 | – | 2,570 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |